Wesfarmers’ strategy sets an expectation for high-single digit earnings growth. However, the reality will still be some way off given growing losses in lithium. There is little room for any competitive risk to Bunnings or Kmart and a lot priced in for growth from these businesses that account for over 85% of enterprise value. Wesfarmers’ strategy continues to shift towards a focus on organic growth. There are opportunities in new product categories for Bunnings and Officeworks, retail media, online marketplaces and production expansion for WesCEF. The message around acquisitions was intriguing – plenty of desire, few viable options.

We have published our periodical chart pack of retailer performance vs market. See attached PDF.  This market share report provides two insights – 1) which retailers are winning and to what extent. 2) Insights about market structure.  If you would like any of the data in Excel at any point, just contact us.

Bunnings store tour and management presentation provided plenty of initiatives the retailer is pursuing to grow sales and margins, despite its large market share and high return on capital. Bunnings sales per square metre is less than half US peer Home Depot. Bunnings will add product ranges like auto, solar and cleaning to lift sales productivity. The company is positioned for margin expansion when the building sector recovers. For each 1% sales improvement, EBT could rise by 2.3% on our estimates. Bunnings also has margin upside from retail media, which could add $100-200 million in EBT over time.

Wesfarmers held its annual strategy day and, as always, delivered a consistent message about its focus on long-term shareholder value creation.  The tone of Wesfarmers annual strategy presentation focused more on growth initiatives and highlighted the progress on productivity and technology investments. While a positive presentation, the detail is unlikely to change consensus earnings expectations and the share price remains very stretched.

Wesfarmers’ strategy day highlighted its growth projects and market share opportunities, despite an increasingly challenging economic environment. The businesses may be relatively resilient, but they are not immune. The combination of slowing sales and rising operating costs keep us cautious.

Wesfarmers reported a strong 1H23 result with EBIT up 13% to $2,160 million. The strength largely reflects good retail earnings and higher chemical and fertiliser prices. Even so, Bunnings profit margins declined and the good group result was partly overshadowed by a very large loss for Catch Group. The prospect for earlier lithium sales will help earnings in FY24e, although project capex is higher.

Wesfarmers strategy day was as comprehensive as usual but did leave us with a few unanswered questions about the finer details of its digital plans, capex outlook and Health ambitions. We expect growth in trade for Bunnings will be difficult without capex and the digital opportunity will take time to build traction. We remain cautious on Bunnings sales outlook.

We would not ordinarily preview a strategy day, but Wesfarmers event on 2 June 2022 will be more interesting than usual given the importance in understanding its digital strategy and its Health segment ambitions. We have outlined the key questions on our mind. While Wesfarmers has very strong existing retail businesses, the future direction and capex required make us cautious about the earnings outlook.

Bunnings accounts for 63% of earnings at Wesfarmers. While a strong business with a leading market position, Bunnings faces challenges in continuing to take market share in our view. The two major areas of share gains are in online and trade. However, in order to succeed in trade and online, Bunnings may need to spend significant capex overhauling its supply chain. At this stage, we do not expect any major shift in supply chain strategy and as a result have modest sales growth and flat margins over the next three years for Bunnings.

We initiate coverage on Wesfarmers. While Wesfarmers retail businesses are well positioned, they have seen significant benefits to sales and earnings over past two years, which will partly reverse. As a result, retail earnings could drop over the next two years. A special dividend is possible near-term. Wesfarmers has over $10 billion in acquisition capacity on our estimates, but in recent times has only made smaller adjacent acquisitions within existing businesses. The creation of a Health segment is one logical extension for the company with an Australian healthcare industry EBITDA profit pool of over $28 billion.